Skip to main content

Data and Information

By Jessica Hagen | 11:32 am | May 07, 2025
The funding comes on the heels of Carta Healthcare’s acquisition of Realyze Intelligence last year.
By HIMSS TV | 12:03 pm | May 06, 2025
Video data is being used for quality assurance and improvement while AI provides insights and information which helps physicians learn more about surgery, say Transform Health Partners' Dr. Peter Billing and Medtronic's George Murgatroyd.
By Adam Ang | 09:16 pm | May 05, 2025
This follows the clearance for heart rate measurement on the FaceHeart mobile app in 2023.
By Adam Ang | 09:08 pm | May 05, 2025
It offers end-to-end, AI-driven digital ecosystem solutions for hospitals and insurers.
HIMSS25
By HIMSS TV | 05:25 pm | May 05, 2025
Population health data can help identify groups requiring specialized interventions and guide their treatments, according to Dr. Robert Jarve, Corewell Health's associate chief medical officer and Davies Award recipient.
By Jessica Hagen | 02:14 pm | May 05, 2025
Project Stargate, an initiative to enhance U.S. AI infrastructure, is exploring international expansion, particularly in the UK.
HIMSS25
By HIMSS TV | 11:25 am | May 05, 2025
Amid rising cyberattacks, Michael Gross, Cleveland Clinic's manager of cybersecurity intelligence, says third-party vendors present an inherent risk that is difficult to defend against, making internal preparedness crucial.
HIMSS25
By HIMSS TV | 04:00 pm | May 01, 2025
Using 400 logic "languages," Dr. R. Ryan Sadeghian, pediatrician and University of Toledo CMIO, and his team are building pediatric-specific AI apps that deliver safe, context-aware responses to support pediatric diagnoses.
HIMSS25
By HIMSS TV | 05:10 pm | April 30, 2025
Michele Krajewski, HIMSS' Global Health Conference Education Committee chair, explains how the committee ensures each year's conference curriculum reflects the interests and needs of HIMSS' diverse membership.
By HIMSS TV | 11:23 am | April 30, 2025
Unlearn leverages digital twin models to simulate how participants may respond to treatments, according to CEO Steve Herne. This approach streamlines clinical trials by enhancing data precision and improving the quality of outcomes.